Trials commence at Papworth for lung isolation device

NHS Innovations East was set up to help NHS staff in the region develop new ideas that will enhance healthcare delivery. One of the latest innovations to emerge is a new device designed to improve patient safety in lung isolation for thoracic surgery.

Clinical trials have now commenced at Papworth Hospital and an exclusive deal has been signed with Phoenix Medical, a P3 Medical company, for the commercial rights to the “Papworth BiVent Endotracheal tube”.

Compared to other techniques, positioning within the appropriate bronchus is claimed to be easier and less time consuming. More importantly, the bifurcated tip design stabilises the inflated “blocker cuff” (the device that isolates the lung), preventing herniation into the trachea or dislodgement from the bronchial orifice. This reduces the risk of displacement when moving the patient, or during surgical handling of the lungs, thereby improving patient safety.

Latest Issues

IDSc Annual Conference 2024

Hilton Birmingham Metropole Hotel
26th - 27th November 2024

IV Forum 2024

Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024

The AfPP Roadshow - Leeds

TBA, Leeds
7th December 2024

The Fifth Annual Operating Theatres Show 2025

Kia Oval, London
11th March 2025, 9:00am - 4:00pm

Infection Prevention and Control 2025 Conference and Exhibition

The National Conference Centre, Birmingham
29th – 30th April 2025

Decontamination and Sterilisation 2025 Conference and Exhibition

The National Conference Centre, Birmingham
11th April 2025